Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 52: 1366-1372, 2006. First published May 4, 2006; 10.1373/clinchem.2005.065854
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.065854v1
52/7/1366    most recent
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kavanagh, L.
Right arrow Articles by Smith, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kavanagh, L.
Right arrow Articles by Smith, T. P.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 2006;52:1366-1372.)
© 2006 American Association for Clinical Chemistry, Inc.


Endocrinology and Metabolism

Specificity and Clinical Utility of Methods for the Detection of Macroprolactin

Lucille Kavanagh1,2, T. Joseph McKenna1,2, Michael N. Fahie-Wilson3, James Gibney1 and Thomas P. Smith1,a

1 Department of Investigative Endocrinology, St. Vincent’s University Hospital, Dublin, Ireland.
2 The Conway Institute of Biomolecular and Biomedical Research, University College, Dublin, Ireland.
3 Department of Clinical Chemistry, Southend Hospital, Essex, United Kingdom.

aAddress correspondence to this author at: Department of Investigative Endocrinology, St. Vincent’s University Hospital, Elm Park, Dublin 4, Ireland. Fax 353-1-209-4981; e-mail thomas.smith{at}ucd.ie.

Background: Increased serum concentrations of macroprolactin are a relatively common cause of misdiagnosis and mismanagement of hyperprolactinemic patients.

Methods: We studied sera from a cohort of 42 patients whose biochemical hyperprolactinemia was explained entirely by macroprolactin. Using 5 pretreatments, polyethylene glycol (PEG), protein A (PA), protein G (PG), anti-human IgG (anti-hIgG), and ultrafiltration (UF), to deplete macroprolactin from sera before immunoassay, we compared residual prolactin concentrations with monomer concentrations obtained by gel-filtration chromatography (GFC). A monomeric prolactin standard was used to assess recovery and specificity of the pretreatment procedures.

Results: Residual prolactin concentrations in all pretreated sera differed significantly (P <0.001) from monomeric concentrations obtained after GFC. PEG underestimated (mean, 75%), whereas PA, PG, anti-hIgG, and UF overestimated (means, 178%, 151%, 178%, and 112%, respectively) the amount of monomer present. Of the 5 methods examined, PEG correlated best with GFC (r = 0.80) followed by PG (r = 0.78), PA (r = 0.72), anti-hIgG (r = 0.70), and UF (r = 0.61). After UF or pretreatment with anti-hIgG or PEG, recovery of monomeric prolactin standard was low: 60%, 85%, and 77% respectively. In contrast, pretreatment with PA or PG gave almost quantitative recovery.

Conclusions: None of the methods examined yielded results identical to the GFC method. PEG pretreatment yielded results that correlated best and is recommended as the first-choice alternative to GFC.




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
L. Beltran, M. N. Fahie-Wilson, T. J. McKenna, L. Kavanagh, and T. P. Smith
Serum Total Prolactin and Monomeric Prolactin Reference Intervals Determined by Precipitation with Polyethylene Glycol: Evaluation and Validation on Common ImmunoAssay Platforms
Clin. Chem., October 1, 2008; 54(10): 1673 - 1681.
[Abstract] [Full Text] [PDF]


Home page
Ann Clin BiochemHome page
M. Fahie-Wilson and D. Halsall
Polyethylene glycol precipitation: proceed with care
Ann Clin Biochem, May 1, 2008; 45(3): 233 - 235.
[Full Text] [PDF]


Home page
Ann Clin BiochemHome page
S. Ram, B. Harris, J. J R Fernando, R. Gama, and M. Fahie-Wilson
False-positive polyethylene glycol precipitation tests for macroprolactin due to increased serum globulins
Ann Clin Biochem, May 1, 2008; 45(3): 256 - 259.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.